Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Clinical trial NCT00905593 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00905593
- Sponsor
- Novartis Pharmaceuticals
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2008-09-01
- Primary completion
- 2011-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.